Start free trial
Markets US Stocks Health Technology Biotechnology

Moderna, Inc
MRNA NASDAQ

MRNA
Moderna, Inc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Timeline Ideas Technicals Financials Index Component

MRNA Stock Chart

Ideas

Videos only
MRNA Analysis
MRNA
, 1D
MRNA: MRNA Analysis

NASDAQ:MRNA

Buy Moderna with Sl of 129 for target 144/157
MRNA
, 60
Long
MRNA: Buy Moderna with Sl of 129 for target 144/157

Buy Moderna with Sl of 129 for target 144/157

Moderna target 250-300. buy @ 175-185
MRNA
, 1D
Long
MRNA: Moderna target 250-300. buy @ 175-185

Strong buy

MRNA 1H 2/10/2021
MRNA
, 60
Long
MRNA: MRNA 1H 2/10/2021

MRNA 1H 2/10/2021

buy @ 165-175 .target 250-300
MRNA
, 1D
Long
MRNA: buy @ 165-175 .target 250-300

buy on dip

Deviation from balance .
MRNA
, 240
Long
MRNA: Deviation from balance .

Long

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Biotechnology
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Timeline

Jul 20 · 2021
Moderna to join S&P 500
Vaccine hero Moderna opens Monday up 6% and finishes the day with a 9.5% bump, building on its share price jump of 10% on Friday on news that the biotech leader is set to get a S&P 500 listing.
More events

News